|
H3F3B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.176880E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.901100E-03 |
| Normal-vs-Stage2 |
2.296000E-02 |
| Normal-vs-Stage3 |
7.787600E-04 |
| Normal-vs-Stage4 |
9.379000E-04 |
| Stage1-vs-Stage2 |
8.806200E-01 |
| Stage1-vs-Stage3 |
5.224000E-01 |
| Stage1-vs-Stage4 |
4.426800E-01 |
| Stage2-vs-Stage3 |
7.927200E-01 |
| Stage2-vs-Stage4 |
7.361600E-01 |
| Stage3-vs-Stage4 |
9.068000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.479200E-03 |
| Normal-vs-AfricanAmerican |
7.062400E-01 |
| Normal-vs-Asian |
4.644700E-04 |
| Caucasian-vs-AfricanAmerican |
8.679700E-02 |
| Caucasian-vs-Asian |
2.274200E-01 |
| AfricanAmerican-vs-Asian |
3.528000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.624330E-04 |
| Normal-vs-Female |
4.043300E-03 |
| Male-vs-Female |
2.565000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.312040E-02 |
| Normal-vs-Age(41-60Yrs) |
1.461170E-03 |
| Normal-vs-Age(61-80Yrs) |
2.096900E-03 |
| Normal-vs-Age(81-100Yrs) |
3.110800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.933000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.012000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.526600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.600200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.051800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.420200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.229800E-01 |
| Classical-VS-Follicular |
6.362200E-02 |
| Classical-VS-Other |
4.385200E-01 |
| Classical-VS-Normal |
8.421300E-03 |
| Tall-VS-Follicular |
5.124600E-01 |
| Tall-VS-Other |
7.194200E-01 |
| Tall-VS-Normal |
1.481930E-02 |
| Follicular-VS-Other |
9.786200E-01 |
| Follicular-VS-Normal |
8.357000E-04 |
| Other-VS-Normal |
7.916000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.152400E-04 |
| Normal-vs-N1 |
5.50579999999412E-05 |
| N0-vs-N1 |
3.635400E-01 |
|
|
